Thursday 19 September 2013

Intrathecal pumps classified under intrathecal drug delivery system are used to deliver small amounts of drug directly to the patient’s spinal fluid for relieving chronic back or spinal pain. This small programmed battery powered pump is surgically implanted under the subcutaneous tissue of the abdomen and is connected to a catheter tunneled to the site of spinal entry. Such devices consist of a computerized pain pump, a catheter and a reservoir which needs to be refilled every 1 to 3 months. In this drug delivery system, a lower dose of medication is required since the drug is delivered directly at the site of action and thus bypasses the phase of circulation throughout the body.


Intrathecal pumps market is categorized on the basis of the following applications:
  • Cancer Pain
  • Neuropathic Pain
  • Facial & Migraine Pain
  • Musculoskeletal Pain
  • Trauma
Globally, North America and western European countries dominates the intrathecal implant pumps market due to high prevalence of chronic or recurring pain in the general population, better reimbursement policies and increased awareness about healthcare and wellbeing in these regions. Emerging economies of Asia, Middle East and Latin America are predicted to incur the highest growth due to growing disease awareness and rising affordability in order to undertake such procedures.

Some of the key factors driving the growth of intrathecal pumps market are global growing elderly population and advances in technology. Increased incidences of cancer and diabetes, improved reimbursement policies and funding by government agencies, particularly in developing countries will further propel the intrathecal pumps market. However, high cost involved in implantation procedure of intrathecal pumps may pose a challenge to the growth of this market.

Some of the major companies contributing to the intrathecal pumps market include Baxter International Inc., Boston Scientific Corporation, Codman and Shurtleff, Inc., Hospira, Inc., Kimberly-Clark Corporation, St. Jude Medical, Inc., Medtronic, Inc., Advanced Bionics LLC, Medasys, Inc., Flowonix Medical, Inc., Smiths Medical ASD, Inc. and Stryker Corporation.


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030

Wednesday 11 September 2013

Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and common. Classic migraine is characterized by sudden change in eye sight and experience partial blindness or double vision. On the other hand common migraine patients witness sudden headaches on one or both the sides of the head. 


Migraine has a serious social and economic impact; According to National Headache Foundation migraine sufferers experience a loss in more than 157 million work days every year. Migraines cause both personal and professional disturbances and add to the overall healthcare costs to a nation. The treatment of migraine headaches is facilitated by administration of preventive medications, to avoid the migraine attacks and abortive medications to relieve the intense and periodic pain. 

The market for anti-migraine drugs witnesses an upward growth curve majorly due to increasing incidences of migraine sufferers. The market can be segmented by type of therapeutic class of drugs involved in the treatment and geography. The major antimigraine drugs used against migraine includes the drugs belonging to the class, triptans such as Sumatriptan, Zolmitriptan, and others. Major factors influencing the growth of this market is the consistent rise in the incidence rates of migraine cases, increased acceptance levels, increased awareness and technological advances in the development of anti-migraine drugs. 

On the other hand patent expirations, high genericization and emergence of local players may mask the growth of the market. Some of the major market players of this market are Abbott Laboratories, Inc. Eisai, Inc., Eli Lilly and Company, Pfizer, Inc., AstraZeneca plc, and GlaxoSmithKline plc.

More reports on Pharmaceuticals market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030

Tuesday 3 September 2013

Erectile dysfunction (ED) is one of the most common sexual problems of men and the susceptibility to this condition increases with aging. The most likely causes of ED are effects of certain medications (anti-depressants and nicotine), chronic diseases (cardiovascular and diabetes), kidney failure, stressful life style and aging. Poor health, obesity, smoking and poor dietary habits may also cause ED. Hesitation in discussing this condition with physicians has resulted in a large pool of untreated patients. There is no gold standard test to identify ED and is usually diagnosed by going through medical history of the patient, a few physical tests and blood tests. Some blood tests are carried out to exclude underlying causes such as diabetes, high cholesterol level and cardiovascular diseases.


The first line therapy for the treatment of ED is use of phosphodiesterase-5 inhibitors (PDE-5) such as sidenafil, tadalafil and vardenafil. These drugs act by augmenting the effect of nitric oxide that relaxes penile muscles and ensures proper blood flow and allows erection. The use of these drugs is contraindicated when a patient is already taking nitrate drugs, anticoagulants and if he is suffering from cardiovascular diseases and diabetes. Viagra (Pfizer), Cialis (Eli Lilly) and Levitra (Bayer) are the leading brand names in this segment.

The market for erectile dysfunction drugs is growing worldwide due to the rapidly increasing prevalence of ED and is predicted to be doubled by the end of 2025. At present, North America represents the largest market for these drugs due to the existence of large number of population affected with ED and high awareness about healthcare and wellbeing. The Urology Care Foundation, an official foundation of the American Urological Association, estimates that at present an average of 15 to 30 million people are suffering from ED across the country with varying levels of distress. The Massachussetts Male Ageing Study suggests that more than 50% of men aged over 40 years of age experience some degree of ED. 

Asia-Pacific represents a potential market for erectile dysfunction drugs due to growing aging population. One of the other factors expected to drive the market in Asia-Pacific region is increasing awareness about the disease and improvement in healthcare infrastructure.

Some of the prominent players operating in this market space are Pfizer, Inc., Eli Lilly, Bayer Healthcare, Johnson & Johnson, GlaxoSmithKline, Sanofi, Astellas Pharma, Inc. and Merck & Co.

More reports on Pharmaceuticals market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030